<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>药春秋 | wechat-feeds</title><link>http://MzI0MDM2NTA4NQ.favicon.privacyhide.com/favicon.ico</link><description>医药行业一致性评价工作在如火如荼的进行中，作为行业的一份子，愿本愚公之念，出蝼蚁 之力，献寸光之策。</description><managingEditor> (hellodword)</managingEditor><pubDate>Wed, 27 Jan 2021 00:05:41 +0800</pubDate><image><url>http://MzI0MDM2NTA4NQ.favicon.privacyhide.com/favicon.ico</url><title>药春秋 | wechat-feeds</title><link>http://MzI0MDM2NTA4NQ.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>化药合成界的“珠峰”，专利期过，国内仿制仍空白！</title><link>https://mp.weixin.qq.com/s/IcvQzuRD1Kjs6leFkiAtMg</link><description></description><content:encoded><![CDATA[化药合成界的“珠峰”，专利期过，国内仿制仍空白！]]></content:encoded><pubDate>Tue, 26 Jan 2021 21:40:31 +0800</pubDate></item><item><title>国采乙肝大品种，过评企业再添1家，竞争进入白热化！</title><link>https://mp.weixin.qq.com/s/cXJidZm4mn7KdncJo4ps7Q</link><description></description><content:encoded><![CDATA[国采乙肝大品种，过评企业再添1家，竞争进入白热化！]]></content:encoded><pubDate>Tue, 26 Jan 2021 21:40:31 +0800</pubDate></item><item><title>21个未过评药，暂停采购；涉及恒瑞、天晴、扬子江...</title><link>https://mp.weixin.qq.com/s/XV0BRyHSFN7cmVkOSmR44Q</link><description></description><content:encoded><![CDATA[21个未过评药，暂停采购；涉及恒瑞、天晴、扬子江...]]></content:encoded><pubDate>Tue, 26 Jan 2021 21:40:31 +0800</pubDate></item><item><title>第三十九批参比目录公示；8种审议未通过原因值得关注</title><link>https://mp.weixin.qq.com/s/zooXHy6xOusxxVij_7T7ow</link><description></description><content:encoded><![CDATA[第三十九批参比目录公示；8种审议未通过原因值得关注]]></content:encoded><pubDate>Tue, 26 Jan 2021 21:40:31 +0800</pubDate></item><item><title>国谈助力，一批药品价格“大跌”！</title><link>https://mp.weixin.qq.com/s/9saDTC7rjEFoV0hJYTeVzQ</link><description></description><content:encoded><![CDATA[国谈助力，一批药品价格“大跌”！]]></content:encoded><pubDate>Tue, 26 Jan 2021 21:40:31 +0800</pubDate></item><item><title>（2021.1.25）一致性评价名单，注射剂扎堆过评</title><link>https://mp.weixin.qq.com/s/rJMOUen8-CGIx4xCjFa08Q</link><description></description><content:encoded><![CDATA[（2021.1.25）一致性评价名单，注射剂扎堆过评]]></content:encoded><pubDate>Mon, 25 Jan 2021 21:51:22 +0800</pubDate></item><item><title>这些临床大品种，带量采购后平均降价67.3%！</title><link>https://mp.weixin.qq.com/s/15Rio1VimrgcWk-4oc4nUg</link><description></description><content:encoded><![CDATA[这些临床大品种，带量采购后平均降价67.3%！]]></content:encoded><pubDate>Mon, 25 Jan 2021 21:51:22 +0800</pubDate></item><item><title>第三十六批参比目录发布，59个新增，6个持证增加...</title><link>https://mp.weixin.qq.com/s/SmqRoTRr5zdCQCWfaLdiYQ</link><description></description><content:encoded><![CDATA[第三十六批参比目录发布，59个新增，6个持证增加...]]></content:encoded><pubDate>Mon, 25 Jan 2021 21:51:22 +0800</pubDate></item><item><title>第四批国采，官方细则解读来了</title><link>https://mp.weixin.qq.com/s/Y479vkvpADGLO2jSbTnO0Q</link><description></description><content:encoded><![CDATA[第四批国采，官方细则解读来了]]></content:encoded><pubDate>Mon, 25 Jan 2021 21:51:22 +0800</pubDate></item><item><title>未过评药品，“大限”已到！</title><link>https://mp.weixin.qq.com/s/oXQow_tsA0MQ32b-7Hz17g</link><description></description><content:encoded><![CDATA[未过评药品，“大限”已到！]]></content:encoded><pubDate>Mon, 25 Jan 2021 21:51:22 +0800</pubDate></item><item><title>医保局似曾相识的“招数”，第四批集采得注意了！</title><link>https://mp.weixin.qq.com/s/whWiAtFS6zDS6lLEST_2nw</link><description></description><content:encoded><![CDATA[医保局似曾相识的“招数”，第四批集采得注意了！]]></content:encoded><pubDate>Sat, 23 Jan 2021 21:41:13 +0800</pubDate></item><item><title>百亿BTK抑制剂市场，多少品种在伺机待发？</title><link>https://mp.weixin.qq.com/s/0l9aBe65PFZwLe-zxna-Hw</link><description></description><content:encoded><![CDATA[百亿BTK抑制剂市场，多少品种在伺机待发？]]></content:encoded><pubDate>Fri, 22 Jan 2021 21:50:28 +0800</pubDate></item><item><title>最新第四批国采竞争格局，3品种超13家企业同台角逐！</title><link>https://mp.weixin.qq.com/s/hLdOajupSVGTR4MYtfc1nQ</link><description></description><content:encoded><![CDATA[最新第四批国采竞争格局，3品种超13家企业同台角逐！]]></content:encoded><pubDate>Fri, 22 Jan 2021 21:50:28 +0800</pubDate></item><item><title>42个自费药议价挂网</title><link>https://mp.weixin.qq.com/s/RCWxbn_BcXQH8RTId_MZeg</link><description></description><content:encoded><![CDATA[42个自费药议价挂网]]></content:encoded><pubDate>Fri, 22 Jan 2021 21:50:28 +0800</pubDate></item><item><title>注意！这些药品不许卖了</title><link>https://mp.weixin.qq.com/s/SxjEuD1OrGvJAeGyOXr-Kg</link><description></description><content:encoded><![CDATA[注意！这些药品不许卖了]]></content:encoded><pubDate>Fri, 22 Jan 2021 21:50:28 +0800</pubDate></item><item><title>（2021.1.21）一致性评价最新名单来了！</title><link>https://mp.weixin.qq.com/s/vjMnaZUuXX5sPSlQg3woWg</link><description></description><content:encoded><![CDATA[（2021.1.21）一致性评价最新名单来了！]]></content:encoded><pubDate>Thu, 21 Jan 2021 21:43:22 +0800</pubDate></item><item><title>31个过评大品种，全国最低价出售</title><link>https://mp.weixin.qq.com/s/anYxoRr1ssOW2OssdElTWQ</link><description></description><content:encoded><![CDATA[31个过评大品种，全国最低价出售]]></content:encoded><pubDate>Thu, 21 Jan 2021 21:43:22 +0800</pubDate></item><item><title>这个药，恢复供应了！</title><link>https://mp.weixin.qq.com/s/0OOqWzsxYnFA36hG96ro-g</link><description></description><content:encoded><![CDATA[这个药，恢复供应了！]]></content:encoded><pubDate>Thu, 21 Jan 2021 21:43:22 +0800</pubDate></item><item><title>第四批国采，最新官方消息流出...</title><link>https://mp.weixin.qq.com/s/LmO4CKlwFxznR8_8s2EyCQ</link><description></description><content:encoded><![CDATA[第四批国采，最新官方消息流出...]]></content:encoded><pubDate>Thu, 21 Jan 2021 21:43:22 +0800</pubDate></item><item><title>一致性评价排行榜：中国生物制药拔得头筹！</title><link>https://mp.weixin.qq.com/s/LN_KobKioieSI0jULF6Zag</link><description></description><content:encoded><![CDATA[一致性评价排行榜：中国生物制药拔得头筹！]]></content:encoded><pubDate>Wed, 20 Jan 2021 21:35:18 +0800</pubDate></item></channel></rss>